Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintenance Treatment With Capecitabine and Bevacizumab Versus Observation After Induction Treatment With Chemotherapy and Bevacizumab as First-line Treatment in Patients With Advanced Colorectal Carcinoma

NCT00442637 is registered in ClinicalTrials.gov with Dutch Colorectal Cancer Group as lead sponsor.

NCT NCT00442637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintenance Treatment With Capecitabine and Bevacizumab Versus Observation After Induction Treatment With Chemotherapy and Bevacizumab as First-line Treatment in Patients With Advanced Colorectal Carcinoma
Lead sponsor
Dutch Colorectal Cancer Group
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2007
Completion date
December 31, 2013
Enrollment
635 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic